2511 fundamentals
An in-depth look to HIGHTIDE THERAPEUTICS INC. operating, investing, and financing activities
2511 free cash flow for H2 24 is -112.44 M HKD. For 2024, 2511 free cash flow was -299.46 M HKD and operating cash flow was -294.81 M HKD.
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
TTM